Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Articaine 4% Versus Mepivacaine 2% for Surgery of Molars Thirds: Splint-mouth Randomized Double Blind Controlled Clinical Trial.

NCT03384160 is registered in ClinicalTrials.gov with Universidade Estadual Paulista Júlio de Mesquita Filho as lead sponsor.

NCT NCT03384160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03384160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Articaine 4% Versus Mepivacaine 2% for Surgery of Molars Thirds: Splint-mouth Randomized Double Blind Controlled Clinical Trial.
Lead sponsor
Universidade Estadual Paulista Júlio de Mesquita Filho
Phase
Not applicable
Overall status
Completed
Start date
December 7, 2017
Completion date
December 4, 2018
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, teeth, impacted